Introduction:

The World Health Organization declared as a pandemic the infection by the coronavirus called SARS-CoV-2 on March 11th, 2020 that emerged in the last days of 2019 in the Chinese province of Wuhan. The disease produced by this coronavirus it is called COVID-19 and it is an entity that has shown low morbidity and mortality in pediatric patients.

Objective:

To examine epidemiological factors, symptomatology, diagnostic and treatment of the disease in pediatric ages.

Methods:

It was reviewed literature using PubMed database to identify articles published until April 30th, 2020, and also reports, series of cases and laboratory data.

Results:

The most frequent onset age was in patients older that 5 years, having 2,5% of seriously ill patients with fever, cough, nasal congestion, dyspnoea, vomiting and diarrhea as the most frequent symptoms. Laboratory data indicated a mean of leukocyte count between 6,1 and 6,8 x 105, lymphopenia with a range between 2,5 and 40%, and an increase of alaniltranferase and creatininfosfoquinase enzymes, in addition to the C reactive protein anti-inflammatory marker with concentrations between 17 and 62,5%. Vertical transmission has not been verified. The most frequently used treatment is Lopinavir/ ritonavir and interferon. Chest X-ray was normal in the 20 to 66 % of the cases. No deaths were recorded in the six series of cases reviewed.

Final considerations:

The infection by SARS-CoV-2 in pediatric ages evolves with a favorable prognosis but more researches on the topic are needed for a best knowledge of this entity.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )